HU Group’s Fujirebio to acquire assays developer ADx NeuroSciences
ADx NeuroSciences will expand its portfolio of advanced biomarkers and antibodies after the deal’s completion.
Deal News
Latest in
Deal News
Elypta raises funds to develop multi-cancer early detection test
The company has two studies in progress, LEVANTIS-0087A for MCED and AURORAX-0087A for kidney cancer recurrence.
Boston Scientific to purchase stake in M.I.Tech for $230m
M.I.Tech has developed a family of conformable, self-expanding metal stents called HANAROSTENT.
OrthoPediatrics signs agreement to acquire Pega Medical
The Fassier-Duval Telescopic Intramedullary System corrects deformity of long bones while preventing or stabilising fractures.
Medical device maker ResMed agrees to buy MEDIFOX DAN for $1bn
The transaction is expected to expand ResMed’s SaaS business footprint outside the US.
BD signs agreement to buy Parata Systems for $1.5bn
Through the acquisition, BD will have access to a new pharmacy automation market segment worth $600m.
StageZero and DiagnoseAtHome to offer blood test in US and Canada
The test identifies gene expression profiles that indicate specific cancers by interrogating mRNA from a whole blood sample.
Pancryos enters licence agreement for macroencapsulation device
The device was shown to boost survival and insulin secretion of cells in preclinical models.